EDESA BIOTECH, INC. Cost of Revenue
EDESA BIOTECH, INC. (EDSA) reported Cost of Revenue of $64.38 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2019-05-08
- EDESA BIOTECH, INC. cost of goods and services sold for the quarter ending 2019-03-31 was $64.38K, a 1.90% decline year-over-year.
- EDESA BIOTECH, INC. cost of goods and services sold for the quarter ending 2018-12-31 was $27.99K, a 899.39% increase year-over-year.
- EDESA BIOTECH, INC. cost of goods and services sold for the quarter ending 2018-09-30 was $19.28K, a 14.24% decline year-over-year.
- EDESA BIOTECH, INC. cost of goods and services sold for the quarter ending 2018-06-30 was $45.62K, a 41.18% decline year-over-year.
- EDESA BIOTECH, INC. cost of goods and services sold for fiscal 2018 was $133.32K, a 46.68% decline from fiscal 2017.
- EDESA BIOTECH, INC. cost of goods and services sold for fiscal 2017 was $250.04K, a 69.45% decline from fiscal 2016.
- EDESA BIOTECH, INC. cost of goods and services sold for fiscal 2016 was $818.57K, a 40.93% increase from fiscal 2015.
- EDESA BIOTECH, INC. cost of goods and services sold for fiscal 2015 was $580.82K, a 23.80% increase from fiscal 2014.
| Period end | Cost of Goods and Services Sold 1 month | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|
| 2019-03-31 | $64.38K 10-Q · filed 2019-05-08 | $92.37K 10-Q · filed 2019-05-08 | $111.65K derived: sum of 3 quarters · filed 2019-05-08 | $157.26K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-12-31 | $27.99K 10-Q · filed 2019-02-05 | $47.27K derived: sum of 2 quarters · filed 2019-02-05 | $92.89K derived: sum of 3 quarters · filed 2019-02-05 | $158.51K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-09-30 | $19.28K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $64.89K derived: sum of 2 quarters · filed 2018-11-30 | $130.51K derived: sum of 3 quarters · filed 2019-05-08 | $133.32K 10-K · filed 2018-11-30 | |
| 2018-06-30 | $45.62K 10-Q · filed 2018-08-08 | $111.24K derived: sum of 2 quarters · filed 2019-05-08 | $114.04K 10-Q · filed 2018-08-08 | $136.52K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2018-03-31 | $65.62K 10-Q · filed 2019-05-08 | $68.42K 10-Q · filed 2019-05-08 | $90.90K derived: sum of 3 quarters · filed 2019-05-08 | $168.46K derived: sum of 4 quarters · filed 2019-05-08 | |
| 2017-12-31 | $2.80K 10-Q · filed 2019-02-05 | $25.28K derived: sum of 2 quarters · filed 2019-02-05 | $102.83K derived: sum of 3 quarters · filed 2019-02-05 | $174.28K derived: sum of 4 quarters · filed 2019-02-05 | |
| 2017-09-30 | $22.48K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | $100.03K derived: sum of 2 quarters · filed 2018-11-30 | $171.48K derived: sum of 3 quarters · filed 2018-11-30 | $250.04K 10-K · filed 2018-11-30 | |
| 2017-06-30 | $77.56K 10-Q · filed 2018-08-08 | $149.00K derived: sum of 2 quarters · filed 2018-08-08 | $227.56K 10-Q · filed 2018-08-08 | $345.18K derived: sum of 4 quarters · filed 2018-08-08 | |
| 2017-03-31 | $71.44K 10-Q · filed 2018-05-07 | $150.01K 10-Q · filed 2018-05-07 | $267.62K derived: sum of 3 quarters · filed 2018-05-07 | $387.61K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | $78.56K 10-Q · filed 2017-02-06 | $196.18K derived: sum of 2 quarters · filed 2017-12-01 | $316.17K derived: sum of 3 quarters · filed 2017-12-01 | $585.07K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-09-30 | $117.61K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $237.60K derived: sum of 2 quarters · filed 2017-12-01 | $506.50K derived: sum of 3 quarters · filed 2017-12-01 | $818.57K 10-K · filed 2017-12-01 | |
| 2016-06-30 | $119.99K 10-Q · filed 2017-08-09 | $388.89K derived: sum of 2 quarters · filed 2017-08-09 | $700.95K 10-Q · filed 2017-08-09 | $710.74K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-03-31 | $268.90K 10-Q · filed 2017-05-09 | $580.96K 10-Q · filed 2017-05-09 | $590.75K derived: sum of 3 quarters · filed 2017-12-01 | $822.75K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-12-31 | $312.06K 10-Q · filed 2017-02-06 | $321.85K derived: sum of 2 quarters · filed 2017-12-01 | $553.85K derived: sum of 3 quarters · filed 2017-12-01 | $796.96K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-09-30 | $9.79K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $241.78K derived: sum of 2 quarters · filed 2017-12-01 | $484.90K derived: sum of 3 quarters · filed 2017-12-01 | $580.82K 10-K · filed 2017-12-01 | |
| 2015-06-30 | $232.00K 10-Q · filed 2016-08-09 | $475.11K derived: sum of 2 quarters · filed 2016-08-09 | $571.04K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $243.12K 10-Q · filed 2016-05-09 | $339.04K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $95.92K 10-Q · filed 2016-02-08 | ||||
| 2014-09-30 | $11.64K 10-K · filed 2016-12-14 | ||||
| 2014-08-31 | $469.15K 10-K · filed 2016-12-14 | ||||
| 2013-08-31 | $57.35K 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |